CD200 and Parkinson disease: In our acute MPTP model of PD, the CD200-deficient mice presented the same degree of MPTP-induced microglial activation and dopaminergic neurodegeneration as their wild-type littermates 7 days after the last MPTP injection, when the lesion has stabilized [32].